A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis



Status:Archived
Conditions:Psoriasis
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:April 2011

Use our guide to learn which trials are right for you!

A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Sequential Group, Multiple-Dose Escalation Study to Evaluate the Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Plaque Psoriasis


The purpose of this study is to explore the efficacy and safety of multiple, escalating
doses of ASP015K when compared to placebo in subjects with moderate to severe plaque
psoriasis.


Following completion of at least 1 week of study drug for all subjects in group 1, the
Sponsor will review the safety information of these subjects prior to enrolling
off-treatment subjects into the next dose group. Dose escalation will continue in this
manner (unless stopping criteria are met) until all groups have completed the study.


We found this trial at
10
sites
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials
Celebration, Florida
?
mi
from
Celebration, FL
Click here to add this to my saved trials
Charleston, South Carolina
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Louisville, Kentucky
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Medford, Oregon
?
mi
from
Medford, OR
Click here to add this to my saved trials
Milwaukee, Wisconsin
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Nashville, Tennessee
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Richmond, Virginia
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Santa Clara, California 95051
?
mi
from
Santa Clara, CA
Click here to add this to my saved trials